JOHN G. FREUND

Profile

First Name

: JOHN

Middle Name

: G.

Last Name

: FREUND

Related Companies
Titles
Company Name
Related People
DIRECTOR
ADVION, INC.
STEVEN A. ELMS, CHANE GRAZIANO, JOHN D. HENION, JOSEPH M. KIELY, DAVID B. PATTESON, ZACHARY SHULMAN, J. KENNETH WALKER, FRANCIS H. ZENIE
DIRECTOR
XENOPORT INC
VINCENT J. ANGOTTI, RONALD W. BARRETT, GREGORY T. BATES, PAUL L. BERNS, GIANNA M. BOSKO, DENNIS M. FENTON, CATHERINE J. FRIEDMAN, WILLIAM G. HARRIS, JERYL L. HILLEMAN, ERNEST MARIO, WILLIAM J. RIEFLIN, DAVID R. SAVELLO, WENDELL WIERENGA
DIRECTOR
PROTEON THERAPEUTICS INC
HUBERT BIRNER, HUBERT BIRNER, PH. D., GAREN BOHLIN, STEVEN K. BURKE, STEVEN K. BURKE, M.D., SCOTT A. CANUTE, GEORGE ELDRIDGE, GEORGE A. ELDRIDGE, TODD FOLEY, F. NICHOLAS FRANANO, JOHN G. FREUND, M.D., DANIEL P. GOTTLIEB, TIM HAINES, PAUL J. HASTINGS, STEPHEN HOFFMAN, TONY KINGSLEY, DMITRY KOBYZEV, MATTHEW P. KOWALSKY, JONATHAN LEFF, DAVID G. LOWE, TIMOTHY NOYES, TIMOTHY P. NOYES, BRENDAN O-LEARY, GREGORY D. PHELPS, DEAN PROFIS, STEVEN ST. PETER, E. SCOTT TONER
DIRECTOR
SI-BONE, INC.
DAVID BONITA, TED DAVIS, TIMOTHY E. DAVIS, JEFFREY DUNN, JEFFREY W. DUNN, LAURA FRANCIS, JOHN FREUND, GREG HINCKLEY, GREGORY K. HINCKLEY, ROBERT E. JOHNSON, KAREN A. LICITRA, DAN MURRAY, GLENN REICIN, MARK REILEY, MARK A. REILEY, JOHN SAVARESE, KEITH C. VALENTINE
DIRECTOR
SUTRO BIOPHARMA INC
MICHAEL DYBBS, DANIEL JANNEY, BRYAN LAWLIS, VIRGIL BRYAN LAWLIS, JOSEPH LOBACKI, WILLIAM J. NEWELL, DANIEL PETREE, MICHAEL ROSS, ARMEN SHANAFELT
DIRECTOR
TETRAPHASE PHARMACEUTICALS INC
GAREN BOHLIN, STEVEN BOYD, JEFFREY A. CHODAKEWITZ, DOUGLAS COLE, LARRY EDWARDS, L. PATRICK GAGE, ERIC M. GORDON, STEVE GULLANS, KARL D. HANDELSMAN, GERRI HENWOOD, DAVID LUBNER, GUY MACDONALD, KEITH MAHER, LAWRENCE MILLER, MARIA STAHL, CHRISTOPHER WATT, ROBERT WEISSKOFF, NANCY J. WYSENSKI
Filings
Filing Date
Filing Type
Source URL
Industry Classifier
Detailed Industry
Revenue Range
Securities
First Sale Date
2020-01-28
D
Link
PHARMACEUTICALS 
PHARMACEUTICAL PREPARATIONS [2834] 
DECLINE TO DISCLOSE 
Equity 
2020-01-24 
2018-08-08
D/A
Link
BIOTECHNOLOGY 
BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] 
DECLINE TO DISCLOSE 
Equity 
2018-05-24 
2018-06-06
D
Link
BIOTECHNOLOGY 
BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] 
DECLINE TO DISCLOSE 
Equity 
2018-05-24 
2016-06-17
D
Link
OTHER 
SURGICAL + MEDICAL INSTRUMENTS + APPARATUS [3841] 
DECLINE TO DISCLOSE 
Equity 
2016-06-02 
2014-06-25
D
Link
OTHER 
 
DECLINE TO DISCLOSE 
Equity, Debt 
2014-06-17 
2014-05-28
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2014-05-13 
2013-11-19
D/A
Link
OTHER 
 
DECLINE TO DISCLOSE 
Equity 
2011-11-14 
2012-11-20
D
Link
PHARMACEUTICALS 
PHARMACEUTICAL PREPARATIONS [2834] 
$25,000,001 - $100,000,000 
Equity 
2012-11-08 
2012-11-20
D/A
Link
OTHER 
 
DECLINE TO DISCLOSE 
Equity 
2011-11-14 
2011-11-17
D
Link
OTHER 
 
DECLINE TO DISCLOSE 
Equity 
2011-11-14